Open access, preprints and open science
1 min read7 pages below
This branch covers access to research and openness in its publication, divided by the policy or practice: access models, mandates, publishing platforms, preprint use, joint professional guidance, open science and pandemic publishing. It leaves journal selection to choosing a journal, journal review procedures to submission and peer review, publishing agreements and reuse permissions to rights and permissions, and clinical-trial disclosure to transparency and disclosure.
- Access and publishing models — subscription and open-access routes, funding, readership, citation effects, repositories and reuse terms
- What open-access mandates require — funder conditions, company mandates, publishing routes and Open Pharma’s position
- Preprint servers and open publishing platforms — server functions, screening, platform review, revision and indexing
- Posting and citing preprints — benefits and risks, journal compatibility, posting, version management and citation guidance
- The joint position statement on preprints and peer review — the 2021 AMWA–EMWA–ISMPP safeguards, quality control, training and writers’ responsibilities
- Open science beyond open access — scope, development, tools, collaboration, incentives and the writer’s role
- Publishing research in a pandemic — compressed timelines, scrutiny, rapid review and the consequences of publishing under pressure